Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Gynecologic 1

Conditions

Myeloproliferative Disorders 1

Interventions

fludarabine 63 Cyclophosphamide 63 venetoclax 57 Azacitidine 52 fludarabine phosphate 50 Specimen Handling 43 Whole-Body Irradiation 40 Mycophenolic Acid 37 ruxolitinib 36 Tacrolimus 35 Melphalan 32 Busulfan 32 Biopsy 31 Cytarabine 30 Stem Cell Transplantation 27 Decitabine 27 Granulocyte Colony-Stimulating Factor 21 asciminib 19 decitabine and cedazuridine drug combination 18 Sirolimus 18 Peripheral Blood Stem Cell Transplantation 18 Injections 18 Thiotepa 17 Filgrastim 17 nilotinib 15 X-Rays 14 Methotrexate 14 Cyclosporine 14 Imatinib Mesylate 13 Magnetic Resonance Spectroscopy 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Aprepitant × Myeloid × 1 year × Clear all

NCT03808805 2025-12-03

APHYPAP

University Hospital, Brest

Phase 3 Completed

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡